beta

GCTK

GlucoTrack Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

integrity applications is dedicated to developing breakthrough innovations in non-invasive glucose monitoring devices. since its founding in 2001, integrity applications has been committed to improving the quality of life for people with diabetes by removing the obstacles of traditional invasive devices, namely painful pricking of fingertips, added costs as a result of disposables, as well as inconvenience. integrity applications has developed a state-of-the-art way to measure glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic in combination with a proprietary algorithm to produce a weighted glucose measurement. after proof of concept in 2002, integrity applications developed the first working prototype, glucotrack in august 2003. glucotrack® model df-f received ce mark approval in june 2013 and kfda in march 2016. glucotrack is currently being marketed in the european union and in south korea. the company went public in november 2011 and is

Market Cap: 6.48 Million

Primary Exchange: NASDAQ

Website: http://www.integrity-app.com/

Shares Outstanding: 20.9 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 2.2159519420693465

Sector: Manufacturing

Industry: Surgical and Medical Instrument Manufacturing

Ethical Flags

Longest drawdown: 597 trading days

From: 2022-03-31 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud